Latest News About - Veterinary Products

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, November 21, 2017

4:57:00 PM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
ml
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Richard Pazdur said: “Reducing the frequency or preventing bleeding episodes is an important part of disease management for patients with hemophilia. Today’s approval provides a new preventative treatment that has been shown to significantly reduce the number of bleeding episodes in patients with hemophilia A with Factor VIII inhibitors,” External link

fda Thursday, November 16, 2017 5:41:00 PM CET

Peter Marks said: “As a molecular and cell biologist and physician, it has been exciting to witness the approval of the first two gene therapies in the U.S. this year. Given the great opportunities that the field of regenerative medicine presents, we have undertaken a rigorous process to clarify our regulations that included solicitation of public input, and I believe today marks a significant step forward for all stakeholders,” External link

fda Thursday, November 16, 2017 3:40:00 PM CET

Richard Pazdur said: “Today’s approval of Zelboraf for patients with ECD demonstrates how we can apply knowledge of the underlying genetic characteristics of certain malignancies to other cancers,” External link

fda Monday, November 6, 2017 5:44:00 PM CET

Darrell Dexter said: "There are so many different products that are going to come on the market," "They range from standard cannabis products right through to veterinary products to cosmetic products to ointments" External link

CBC Thursday, November 2, 2017 11:44:00 PM CET

Scott Gottlieb added: “We have an obligation to provide caregivers and patients with the confidence that drugs making cancer treatment claims have been carefully evaluated for safety, efficacy, and quality, and are monitored by the FDA once they’re on the market,” “We recognize that there’s interest in developing therapies from marijuana and its components, but the safest way for this to occur is through the drug approval process not through unsubstantiated claims made on a website. We support sound, scientifically-based research using components derived from marijuana, and we’ll continue to work with product developers who are interested in bringing safe, effective, and quality products to market” External link

fda Wednesday, November 1, 2017 5:29:00 PM CET

Richard Pazdur said: "Mantle cell lymphoma is a particularly aggressive cancer," External link

prnewswire Tuesday, October 31, 2017 5:26:00 PM CET

Lisa Farbstein said: "The security measures affect all individuals, international passengers and U.S. citizens, traveling to the United States from a last point of departure international location," External link

lacrossetribune Thursday, October 26, 2017 7:45:00 AM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.